October 1, 2012
Osaka District Court The Osaka District Court ruled against Takeda Pharmaceutical on September 27 in a lawsuit filed by the company against eight generic drug manufacturers that launched generic versions of the type 2 diabetes treatment Actos (pioglitazone) following NHI...read more